Friday, November 13, 2026Moscow
Society

Residents of Saransk told about antitumor compound based on gold

Residents of Saransk reported a substance with gold, which in the future can help in the fight against tumors

Published
Residents of Saransk told about antitumor compound based on gold

Residents of Saransk reported a substance with gold, which in the future can help in the fight against tumors.

According to the plan, a new type of drugs can appear on the basis of the compound. Means with gold, scientists believe a possible replacement for drugs that use platinum.

The created complex acts on cancer cells more strongly at a lower dose. Gold is needed to obtain such a substance very little.

The complexes were tested on breast and cervical cancer cells. One of them acted selectively: for healthy cells, it was noticeably less toxic than for tumor cells. Scientists call this result encouraging.

Source: Московский комсомолец ↗

Share

More on This Story

The son of Dmitry Gudkov committed suicide
SocietyThe son of Dmitry Gudkov committed suicide

Ivan Gudkov, the son of oppositionist Dmitry Gudkov and his first wife, Sophia Kapkova, committed suicide. Ksenia Sobchak said that he reported on the difficulties of emigration

Яна Соловьева
In the fighter MMA “Nikarho” shot from the trauma in the center of Vladikavkaz
SocietyIn the fighter MMA “Nikarho” shot from the trauma in the center of Vladikavkaz

In the center of Vladikavkaz, a man was injured as a result of shooting from a traumatic pistol, the Ministry of Internal Affairs for North Ossetia reports.

Виктория Хабарова, Александра Озерова
PCT reported 23 complaints of sick tourists from a hotel in Turkey
SocietyPCT reported 23 complaints of sick tourists from a hotel in Turkey

Since August, insurance companies have recorded 23 appeals from tourists vacationing in the Turkish hotel Bosphorus Sorgun, with similar complaints of poor health, told RBC in the press service of the Russian Union of Travel Industry (PCT).

Евгения Сорокина, Виктория Хабарова
The EIA Briefing

Keep reading, every morning.

The stories that matter, chosen by our editors and in your inbox before 7 a.m. — every weekday.

No spam. Unsubscribe anytime.